Orphan Drug Marketing
Locating physicians that treat patients who would benefit from your orphan drug can be a costly, “needle-in-a-haystack” type of endeavor. The Schwartz Group can limit the costs and streamline the process of reaching and detailing targeted physicians in an effort to change prescribing habits. We have successfully partnered with leading orphan drug companies to engage physicians and uncover new opportunities for our clients’ therapies.
HIGHLY-TARGETED, CUSTOMIZED CAMPAIGNS
We work on a daily basis with our clients to ensure the success of every campaign. Working closely with your field sales force and regulatory department, we implement proven approaches to locating prospective opportunities and make refinements in consultation with our clients whenever needed. Our orphan drug marketing campaigns are therefore highly-collaborative and individually-optimized to locate and identify potential consumers, producing measurable returns on investment for our partners.
We believe the success of every campaign depends on collaborative and responsive partnership. Our internal efficiency allows us to make instant changes to the strategic focus of any campaign based on the direction we receive from our client.
Case Study
Rare autosomal disease
Growing biotechnology company
Identify new opportunities for treatment of rare inherited blood disorder
A two-pronged Schwartz Inside Partnering (SIP) program executed in separate phases of marketing intelligence-gathering and lead generation
Phase I: Market Intelligence-Gathering
- Using 5 Schwartz Inside Partners (SIPs) over a six-month period, TSG was able to identify 891 providers treating 2,091 patients with an autosomal dominantly inherited blood disorder as part of the lead generation effort.
In addition to identifying targets who are treating patients with the disease, TSG was able to confirm 6,519 providers who are not treating patients, creating a comprehensive list of providers not requiring follow-up by sales representatives.
Phase II: Lead Generation
- Using 4 SIPs, TSG was able to generate 44 new orders of product shipped to the providers office or preferred treatment site within the first 6 months of the Schwartz Inside Partnering Program.
- Each SIP was assigned to three outside sales representative to generate leads. The SIPs were also given one vacant or white space territory for which they were responsible for establishing and maintaining a relationship with top providers. Our client was able to ensure territories covered by the Schwartz Inside Partnerning program were kept current of all updates about the product as well as promotion of their home infusion services for patients without an existing treatment site.